SlideShare une entreprise Scribd logo
1  sur  10
Télécharger pour lire hors ligne
Dr. P.Naina Mohamed
Pharmacologist
Introduction
 Sodium-Glucose Linked Transporter 2 (SGLT2) inhibitors are a new class of oral drugs to treat
type 2 diabetes mellitus (Type 2 DM).
 Sodium-Glucose Linked Transporters (SGLT) or Sodium-dependent glucose cotransporters
are a family of glucose transporter.
 There are two kinds of SGLTs: SGLT1 and SGLT2.
 SGLT1 is found in intestinal mucosa of the small intestine and proximal straight tubule (PST) of
nephron.
 SGLT2 is found in proximal convoluted tubule (PCT) of nephron.
 Both SGLT1 and SGLT2 are responsible for the renal glucose reabsorption.
 Approximately 90% of glucose is reabsorbed by SGLT2 at PCT and only around 10% of glucose is
reabsorbed by SGLT1 at PST.
SGLT2 Inhibitors SGLT2 Inhibitors include:
 Dapagliflozin (Farxiga)
 Canagliflozin (Invokana)
 Empagliflozin (Jardiance)
 Ipragliflozin
 Tofogliflozin
 Remogliflozin etabonate
 Sergliflozin etabonate
 Dapagliflozin is the first drug to be developed in this class. But, its approval was
rejected in 2012 by Food and Drug Administration (FDA) due to safety concerns. Later it
was approved by FDA on 8th
Jan 2014. Previously it was approved by EU in 2011.
 Canagliflozin is the first drug to be approved by FDA which got the approval by 29th
Mar 2013.
 Empagliflozin got the FDA approval by 1st
Aug 2014.
 Ipragliflozin (ASP-1941), is in Phase III clinical trials.
 Tofogliflozin, is also in Phase III clinical trials.
 Remogliflozin etabonate, is in phase IIb trials.
 Sergliflozin etabonate, discontinued after Phase II trials.
 SGLT2 inhibitors can improve glycemic control in conjunction with exercise and a
healthy diet.
 They can be used either alone or in combination with other antidiabetics such as
metformin, sulfonylureas, pioglitazone and insulin.
Mechanism of Action
Effects on Weight
Effects on Blood Pressure
Adverse Effects
Contraindications
Possible Drug Interactions
References
http://diabetes.diabetesjournals.org/content/61/9/2199.full
http://www.medscape.com/viewarticle/760248
http://www.diabetesincontrol.com/articles/91-/14495-sglt2-inhibitors-a-new
http://spectrum.diabetesjournals.org/content/22/2/92.full.pdf
http://www.micromedexsolutions.com
http://www.diabetes.co.uk/diabetes-medication/sglt2-inhibitors.html
http://
www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htm
http://
www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm3808
29.htm
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/uc
m407637.htm?
source=govdelivery&utm_medium=email&utm_source=govdelivery

Contenu connexe

Tendances

SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsahvc0858
 
Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and futurePriyanka Thakur
 
Dpp4i earlier the better ! (1)
Dpp4i  earlier the better ! (1)Dpp4i  earlier the better ! (1)
Dpp4i earlier the better ! (1)Faraz Farishta
 
Sglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseasesSglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseasesYogesh Shilimkar
 
Gliclazide MR in the management of Type 2 Diabetes Mellitus
Gliclazide MR in the management of Type 2 Diabetes MellitusGliclazide MR in the management of Type 2 Diabetes Mellitus
Gliclazide MR in the management of Type 2 Diabetes MellitusEndocrinology Department, BSMMU
 
New treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
New treatment for Diabetes Mellitus and Drugs to treat HypoglycemiaNew treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
New treatment for Diabetes Mellitus and Drugs to treat HypoglycemiaFarazaJaved
 
Vildagliptin in the management of Type 2 Diabetes mellitus
Vildagliptin in the management of Type 2 Diabetes mellitusVildagliptin in the management of Type 2 Diabetes mellitus
Vildagliptin in the management of Type 2 Diabetes mellitusEndocrinology Department, BSMMU
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Sulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightSulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightRxVichuZ
 

Tendances (20)

SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
 
Dapagliflozin
Dapagliflozin Dapagliflozin
Dapagliflozin
 
SGLT-2
SGLT-2 SGLT-2
SGLT-2
 
Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and future
 
Empagliflozin
EmpagliflozinEmpagliflozin
Empagliflozin
 
Antidiabetic drugs
Antidiabetic drugsAntidiabetic drugs
Antidiabetic drugs
 
Dpp4i earlier the better ! (1)
Dpp4i  earlier the better ! (1)Dpp4i  earlier the better ! (1)
Dpp4i earlier the better ! (1)
 
SGLT2 inhibitors
SGLT2 inhibitorsSGLT2 inhibitors
SGLT2 inhibitors
 
Sglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseasesSglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseases
 
glyxambi
glyxambiglyxambi
glyxambi
 
Empagliflozin
EmpagliflozinEmpagliflozin
Empagliflozin
 
Linagliptin
LinagliptinLinagliptin
Linagliptin
 
Gliclazide MR in the management of Type 2 Diabetes Mellitus
Gliclazide MR in the management of Type 2 Diabetes MellitusGliclazide MR in the management of Type 2 Diabetes Mellitus
Gliclazide MR in the management of Type 2 Diabetes Mellitus
 
New treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
New treatment for Diabetes Mellitus and Drugs to treat HypoglycemiaNew treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
New treatment for Diabetes Mellitus and Drugs to treat Hypoglycemia
 
SGLT2 inhibitors - what's new?
SGLT2 inhibitors - what's new?SGLT2 inhibitors - what's new?
SGLT2 inhibitors - what's new?
 
Vildagliptin in the management of Type 2 Diabetes mellitus
Vildagliptin in the management of Type 2 Diabetes mellitusVildagliptin in the management of Type 2 Diabetes mellitus
Vildagliptin in the management of Type 2 Diabetes mellitus
 
Sitagliptin
SitagliptinSitagliptin
Sitagliptin
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Sulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightSulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insight
 
Dpp 4 inhibitors
Dpp 4 inhibitorsDpp 4 inhibitors
Dpp 4 inhibitors
 

En vedette

Presentation glucose transporters
Presentation glucose transportersPresentation glucose transporters
Presentation glucose transporterskiro94
 
Animal phys chapter 5 part 2
Animal phys chapter 5 part 2Animal phys chapter 5 part 2
Animal phys chapter 5 part 2stephaniehudon
 
Carrier mediated drug transport
Carrier mediated drug transportCarrier mediated drug transport
Carrier mediated drug transportsamudragupta123
 
Glut1 Abstract
Glut1 AbstractGlut1 Abstract
Glut1 AbstractCary Trent
 
Cell membrane and transport
Cell membrane and transportCell membrane and transport
Cell membrane and transportAmit Kumar
 
Transport across the memebrane
Transport across the memebraneTransport across the memebrane
Transport across the memebranedharam bir
 
Glucose receptors1
Glucose receptors1Glucose receptors1
Glucose receptors1Agasya raj
 
Passive transporters in cell membrane
Passive transporters in cell membranePassive transporters in cell membrane
Passive transporters in cell membraneNafly Hussain
 
Digestion and absorption of carbohydrates
Digestion and absorption of carbohydratesDigestion and absorption of carbohydrates
Digestion and absorption of carbohydratesNamrata Chhabra
 

En vedette (14)

Active transpot
Active transpotActive transpot
Active transpot
 
Presentation glucose transporters
Presentation glucose transportersPresentation glucose transporters
Presentation glucose transporters
 
Animal phys chapter 5 part 2
Animal phys chapter 5 part 2Animal phys chapter 5 part 2
Animal phys chapter 5 part 2
 
Animal phys chapter 5
Animal phys chapter 5Animal phys chapter 5
Animal phys chapter 5
 
Insulin Actions and Receptors
Insulin Actions and  Receptors Insulin Actions and  Receptors
Insulin Actions and Receptors
 
Carrier mediated drug transport
Carrier mediated drug transportCarrier mediated drug transport
Carrier mediated drug transport
 
Glut1 Abstract
Glut1 AbstractGlut1 Abstract
Glut1 Abstract
 
Cell membrane and transport
Cell membrane and transportCell membrane and transport
Cell membrane and transport
 
Transport across the memebrane
Transport across the memebraneTransport across the memebrane
Transport across the memebrane
 
bd
bdbd
bd
 
Glucose receptors1
Glucose receptors1Glucose receptors1
Glucose receptors1
 
Passive transporters in cell membrane
Passive transporters in cell membranePassive transporters in cell membrane
Passive transporters in cell membrane
 
Glucose transport
Glucose transportGlucose transport
Glucose transport
 
Digestion and absorption of carbohydrates
Digestion and absorption of carbohydratesDigestion and absorption of carbohydrates
Digestion and absorption of carbohydrates
 

Similaire à SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:

A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...
A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...
A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...Kate Campbell
 
Everything you need to know about Dapagliflozin mechanism of action
Everything you need to know about Dapagliflozin mechanism of actionEverything you need to know about Dapagliflozin mechanism of action
Everything you need to know about Dapagliflozin mechanism of actionSUMIT SHARMA
 
Zeeshan Siddique Pharmacology.pptx
Zeeshan Siddique Pharmacology.pptxZeeshan Siddique Pharmacology.pptx
Zeeshan Siddique Pharmacology.pptxZeeshan Siddique
 
Dapagliflozin in Clinical Trial212.pptx
Dapagliflozin in Clinical Trial212.pptxDapagliflozin in Clinical Trial212.pptx
Dapagliflozin in Clinical Trial212.pptxAliShahen2
 
sodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptx
sodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptxsodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptx
sodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptxLawanYarimaMasaba
 
T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)
T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)
T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)Sarfraz Khan
 
List of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdf
List of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdfList of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdf
List of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdfDoriaFang
 
Antidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistryAntidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistryDr Duggirala Mahendra
 
Oral hypoglycaemic agents
Oral hypoglycaemic agents   Oral hypoglycaemic agents
Oral hypoglycaemic agents Haider Haider
 
Current concept of type 2 DM
Current concept of type 2 DMCurrent concept of type 2 DM
Current concept of type 2 DMDr. Lin
 
Recent advances in treatment of diabetes melltius
Recent advances in treatment of diabetes melltiusRecent advances in treatment of diabetes melltius
Recent advances in treatment of diabetes melltiusRajesh Yadav
 
Newer OHA and insulin
Newer OHA and insulinNewer OHA and insulin
Newer OHA and insulinNamrataRaja1
 

Similaire à SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes: (20)

Empagliflozin
EmpagliflozinEmpagliflozin
Empagliflozin
 
Insulin secretagogues
Insulin secretagoguesInsulin secretagogues
Insulin secretagogues
 
A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...
A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...
A Medical Literature Review On Canagliflozin And Dapagliflozin And The Role O...
 
Everything you need to know about Dapagliflozin mechanism of action
Everything you need to know about Dapagliflozin mechanism of actionEverything you need to know about Dapagliflozin mechanism of action
Everything you need to know about Dapagliflozin mechanism of action
 
Zeeshan Siddique Pharmacology.pptx
Zeeshan Siddique Pharmacology.pptxZeeshan Siddique Pharmacology.pptx
Zeeshan Siddique Pharmacology.pptx
 
Dapagliflozin in Clinical Trial212.pptx
Dapagliflozin in Clinical Trial212.pptxDapagliflozin in Clinical Trial212.pptx
Dapagliflozin in Clinical Trial212.pptx
 
sodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptx
sodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptxsodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptx
sodium Glucose co transporter 2 inhibitors GLIFLOZINS .pptx
 
T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)
T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)
T2DM Therapeutic Area Landscape: SGLT2 and GLP1 (USA Market)
 
List of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdf
List of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdfList of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdf
List of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdf
 
Antidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistryAntidiabetic agents-medicinal chemistry
Antidiabetic agents-medicinal chemistry
 
Oral hypoglycaemic agents
Oral hypoglycaemic agents   Oral hypoglycaemic agents
Oral hypoglycaemic agents
 
Oral hypoglycemic agent
Oral hypoglycemic agent Oral hypoglycemic agent
Oral hypoglycemic agent
 
Dpp4 inhibitors
Dpp4  inhibitorsDpp4  inhibitors
Dpp4 inhibitors
 
Drugs in t2 dm jap_2015_16
Drugs in t2 dm jap_2015_16Drugs in t2 dm jap_2015_16
Drugs in t2 dm jap_2015_16
 
Current concept of type 2 DM
Current concept of type 2 DMCurrent concept of type 2 DM
Current concept of type 2 DM
 
Recent advances in treatment of diabetes melltius
Recent advances in treatment of diabetes melltiusRecent advances in treatment of diabetes melltius
Recent advances in treatment of diabetes melltius
 
Newer OHA and insulin
Newer OHA and insulinNewer OHA and insulin
Newer OHA and insulin
 
Type 2 Diabetes
Type 2 Diabetes Type 2 Diabetes
Type 2 Diabetes
 
Oral hypoglycemic drugs
Oral hypoglycemic drugsOral hypoglycemic drugs
Oral hypoglycemic drugs
 
Sulfonyleureas in Managing T2DM by Dr Selim
Sulfonyleureas  in Managing T2DM by Dr SelimSulfonyleureas  in Managing T2DM by Dr Selim
Sulfonyleureas in Managing T2DM by Dr Selim
 

Plus de Naina Mohamed, PhD

Drug interactions of Metformin
Drug interactions of MetforminDrug interactions of Metformin
Drug interactions of MetforminNaina Mohamed, PhD
 
Drug Interactions of Vorapaxar
Drug Interactions of VorapaxarDrug Interactions of Vorapaxar
Drug Interactions of VorapaxarNaina Mohamed, PhD
 
Drug interactions of Cilostazol
Drug interactions of CilostazolDrug interactions of Cilostazol
Drug interactions of CilostazolNaina Mohamed, PhD
 
Drug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitorsDrug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitorsNaina Mohamed, PhD
 
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)Naina Mohamed, PhD
 
Drug Interactions of ADP receptor Blockers (Antiplatelets)
 Drug Interactions of ADP receptor Blockers (Antiplatelets) Drug Interactions of ADP receptor Blockers (Antiplatelets)
Drug Interactions of ADP receptor Blockers (Antiplatelets)Naina Mohamed, PhD
 
Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)Naina Mohamed, PhD
 
Fasting associated adverse effects
Fasting associated adverse effects Fasting associated adverse effects
Fasting associated adverse effects Naina Mohamed, PhD
 
Clinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of FibrinolyticsClinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of FibrinolyticsNaina Mohamed, PhD
 
Drug interactions of Urokinase
Drug interactions of UrokinaseDrug interactions of Urokinase
Drug interactions of UrokinaseNaina Mohamed, PhD
 
Drug Interactions of Streptokinase:
 Drug Interactions of Streptokinase: Drug Interactions of Streptokinase:
Drug Interactions of Streptokinase:Naina Mohamed, PhD
 
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)Naina Mohamed, PhD
 
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:Naina Mohamed, PhD
 
Complementary and alternative therapies for erectile dysfunction
Complementary and alternative  therapies for erectile dysfunctionComplementary and alternative  therapies for erectile dysfunction
Complementary and alternative therapies for erectile dysfunctionNaina Mohamed, PhD
 
Drug interactions of Dabigatran
Drug interactions of DabigatranDrug interactions of Dabigatran
Drug interactions of DabigatranNaina Mohamed, PhD
 
Drug interactions of Argatroban
Drug interactions of ArgatrobanDrug interactions of Argatroban
Drug interactions of ArgatrobanNaina Mohamed, PhD
 
Drug interactions of Heparinoids
Drug interactions of HeparinoidsDrug interactions of Heparinoids
Drug interactions of HeparinoidsNaina Mohamed, PhD
 
Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)Naina Mohamed, PhD
 

Plus de Naina Mohamed, PhD (20)

Drug interactions of Metformin
Drug interactions of MetforminDrug interactions of Metformin
Drug interactions of Metformin
 
Drug Interactions of Vorapaxar
Drug Interactions of VorapaxarDrug Interactions of Vorapaxar
Drug Interactions of Vorapaxar
 
Drug interactions of Cilostazol
Drug interactions of CilostazolDrug interactions of Cilostazol
Drug interactions of Cilostazol
 
Drug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitorsDrug Interactions of Glycoprotein IIB/IIIA inhibitors
Drug Interactions of Glycoprotein IIB/IIIA inhibitors
 
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
Drug Interactions of Dipyridamole (Antiplatelt - Adenosine reuptake inhibitor)
 
Drug Interactions of ADP receptor Blockers (Antiplatelets)
 Drug Interactions of ADP receptor Blockers (Antiplatelets) Drug Interactions of ADP receptor Blockers (Antiplatelets)
Drug Interactions of ADP receptor Blockers (Antiplatelets)
 
Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)Drug interactions of Aspirin (Antiplatelet)
Drug interactions of Aspirin (Antiplatelet)
 
Fasting associated adverse effects
Fasting associated adverse effects Fasting associated adverse effects
Fasting associated adverse effects
 
Clinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of FibrinolyticsClinically Important Drug Interactions of Fibrinolytics
Clinically Important Drug Interactions of Fibrinolytics
 
Drug interactions of Urokinase
Drug interactions of UrokinaseDrug interactions of Urokinase
Drug interactions of Urokinase
 
Drug Interactions of Streptokinase:
 Drug Interactions of Streptokinase: Drug Interactions of Streptokinase:
Drug Interactions of Streptokinase:
 
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
Drug Interactions of Recombinant Tissue Plasminogen Activators (rtPA)
 
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
Clinically Important DRUG INTERACTIONS OF ANTICOAGULANTS:
 
Complementary and alternative therapies for erectile dysfunction
Complementary and alternative  therapies for erectile dysfunctionComplementary and alternative  therapies for erectile dysfunction
Complementary and alternative therapies for erectile dysfunction
 
Drug interactions of Dabigatran
Drug interactions of DabigatranDrug interactions of Dabigatran
Drug interactions of Dabigatran
 
Drug interactions of Argatroban
Drug interactions of ArgatrobanDrug interactions of Argatroban
Drug interactions of Argatroban
 
Drug interactions of Hirudins
Drug interactions of HirudinsDrug interactions of Hirudins
Drug interactions of Hirudins
 
Drug interactions of Heparinoids
Drug interactions of HeparinoidsDrug interactions of Heparinoids
Drug interactions of Heparinoids
 
Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)Drug interactions of Low Molecular weight Heparins (LMWHs)
Drug interactions of Low Molecular weight Heparins (LMWHs)
 
Drug interactions of Heparin
Drug interactions of HeparinDrug interactions of Heparin
Drug interactions of Heparin
 

Dernier

Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationMJDuyan
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapitolTechU
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxSaurabhParmar42
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17Celine George
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxDr. Santhosh Kumar. N
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphNetziValdelomar1
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxKatherine Villaluna
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 

Dernier (20)

Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive Education
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptx
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptx
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptx
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a Paragraph
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptx
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 

SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes: